TLR8 | Toll-like receptor 8 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
TMSB4X | Thymosin beta 4, X-linked | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FAM9C | Family with sequence similarity 9, member C | Predicted membrane proteins
| | | | | Tissue enriched |
ATXN3L | Ataxin 3-like | Enzymes
| | | | | Tissue enriched |
EGFL6 | EGF-like-domain, multiple 6 | Predicted secreted proteins
| | | | | Tissue enriched |
TCEANC | Transcription elongation factor A (SII) N-terminal and central domain containing | | | | | | Mixed |
RAB9A | RAB9A, member RAS oncogene family | | | | | | Expressed in all |
TRAPPC2 | Trafficking protein particle complex 2 | Disease related genes
| | | | | Expressed in all |
OFD1 | Oral-facial-digital syndrome 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
GEMIN8 | Gem (nuclear organelle) associated protein 8 | | | | | | Expressed in all |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
FANCB | Fanconi anemia, complementation group B | Disease related genes
| | | | | Tissue enhanced |
MOSPD2 | Motile sperm domain containing 2 | Predicted membrane proteins
| | | | | Mixed |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
ASB11 | Ankyrin repeat and SOCS box containing 11 | Predicted membrane proteins
| | | | | Group enriched |
PIGA | Phosphatidylinositol glycan anchor biosynthesis, class A | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
FIGF | C-fos induced growth factor (vascular endothelial growth factor D) | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PIR | Pirin (iron-binding nuclear protein) | Enzymes Plasma proteins
| | | | | Expressed in all |
BMX | BMX non-receptor tyrosine kinase | Enzymes
| | | | | Mixed |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM27 | Transmembrane protein 27 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CA5B | Carbonic anhydrase VB, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
ZRSR2 | Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 | Cancer-related genes
| | | | | Expressed in all |
AP1S2 | Adaptor-related protein complex 1, sigma 2 subunit | Disease related genes
| | | | | Expressed in all |
GRPR | Gastrin-releasing peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
MAGEB17 | Melanoma antigen family B, 17 | | | | | | Tissue enriched |
CTPS2 | CTP synthase 2 | Enzymes
| | | | | Expressed in all |
S100G | S100 calcium binding protein G | | | | | | Tissue enriched |
SYAP1 | Synapse associated protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
TXLNG | Taxilin gamma | | | | | | Expressed in all |
RBBP7 | Retinoblastoma binding protein 7 | | | | | | Expressed in all |
REPS2 | RALBP1 associated Eps domain containing 2 | Predicted secreted proteins
| | | | | Mixed |
NHS | Nance-Horan syndrome (congenital cataracts and dental anomalies) | Disease related genes Plasma proteins
| | | | | Mixed |
SCML1 | Sex comb on midleg-like 1 (Drosophila) | | | | | | Expressed in all |
RAI2 | Retinoic acid induced 2 | | | | | | Mixed |
BEND2 | BEN domain containing 2 | | | | | | Tissue enriched |
SCML2 | Sex comb on midleg-like 2 (Drosophila) | Plasma proteins
| | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
RS1 | Retinoschisin 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
PPEF1 | Protein phosphatase, EF-hand calcium binding domain 1 | Enzymes Plasma proteins
| | | | | Group enriched |
PHKA2 | Phosphorylase kinase, alpha 2 (liver) | Disease related genes
| | | | | Expressed in all |
GPR64 | G protein-coupled receptor 64 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PDHA1 | Pyruvate dehydrogenase (lipoamide) alpha 1 | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
MAP3K15 | Mitogen-activated protein kinase kinase kinase 15 | Enzymes
| | | | | Tissue enriched |
SH3KBP1 | SH3-domain kinase binding protein 1 | Cytoskeleton related proteins
| | | | | Expressed in all |
CXorf23 | Chromosome X open reading frame 23 | Mitochondrial proteins
| | | | | Expressed in all |
MAP7D2 | MAP7 domain containing 2 | | | | | | Tissue enhanced |
EIF1AX | Eukaryotic translation initiation factor 1A, X-linked | | | | | | Expressed in all |
RPS6KA3 | Ribosomal protein S6 kinase, 90kDa, polypeptide 3 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |